Naviscan takes hi-res PET scanner forward with $6.5m financing:
This article was originally published in Clinica
A private San Diego, California-based developer of high resolution PET imaging systems, Naviscan PET Systems, has raised $6.5m in a second round of financing led by Sanderling Ventures and included the participation of Mayo Medical Ventures. The funds will be used to commercialise Naviscan's PEM Flex Solo PET scanner, as well as to develop proprietary molecular imaging agents, licensed from Mayo Clinic, for use in conjunction with the device to aid early detection of cancers. Cleared by the US FDA in September 2003, the PEM Flex system is designed to guide challenging radiological and surgical procedures and minimally-invasive therapy in the breast and prostate.